glaucoma

47
Glaucoma Glaucoma Dr Lee Ming Yueh Dr Lee Ming Yueh Ophthalmology Unit Ophthalmology Unit Penang Hospital Penang Hospital

Upload: ophthalmicdocs-chiong

Post on 31-May-2015

277 views

Category:

Health & Medicine


4 download

DESCRIPTION

Glaucoma. A lecture from Dr. Lee from Penang Medical College

TRANSCRIPT

Page 1: Glaucoma

GlaucomaGlaucoma

Dr Lee Ming YuehDr Lee Ming Yueh

Ophthalmology UnitOphthalmology Unit

Penang HospitalPenang Hospital

Page 2: Glaucoma

Glaucoma is a sight threatening disease Glaucoma is a sight threatening disease which can cause irreversible visual losswhich can cause irreversible visual loss

Baltimore Eye Survey:Baltimore Eye Survey:

- - by the year 2000 by the year 2000 > 66.8 million primary glaucoma > 66.8 million primary glaucoma

> 6.7 million bilateral > 6.7 million bilateral blindness blindness

Page 3: Glaucoma

DefinitionDefinition

A spectrum of disease characterized byA spectrum of disease characterized by

- progressive optic neuropathy- progressive optic neuropathy

- visual field loss- visual field loss

** IOP is an important risk factor. IOP is an important risk factor.

Page 4: Glaucoma

Optic NeuropathyOptic Neuropathy

Page 5: Glaucoma

Progression of

Glaucomatous

Optic Neuropathy

Page 6: Glaucoma

Visual Field Visual Field LossLoss

Page 7: Glaucoma

Classification:Classification:

Open Angle GlaucomaOpen Angle Glaucoma

Close Angle GlaucomaClose Angle Glaucoma

Congenital GlaucomaCongenital Glaucoma

Page 8: Glaucoma
Page 9: Glaucoma
Page 10: Glaucoma

Trabecular meshwork acts like a sieve…Trabecular meshwork acts like a sieve…

Page 11: Glaucoma

Angle StructureAngle Structure

Page 12: Glaucoma

Open Angle GlaucomaOpen Angle Glaucoma

PrimaryPrimaryRisk factors :Risk factors : Age > 60Age > 60

Race – negro, darkRace – negro, darkFamily history – siblings 4xFamily history – siblings 4x

- parents 2x- parents 2xOcular ds – myopia, Retinitis Ocular ds – myopia, Retinitis

PigmentosaPigmentosaCardiovascular ds, DM, SAS, Cardiovascular ds, DM, SAS,

migraine ?migraine ?SecondarySecondarya.a. Pretrabecular – neovascular/inflammatory membranePretrabecular – neovascular/inflammatory membraneb. b. Trabecular- RBC, pseudoexfoliation, pigmentTrabecular- RBC, pseudoexfoliation, pigmentc.c. Post Trabecular- TED, Carotid-cavernous fistulaPost Trabecular- TED, Carotid-cavernous fistula

Page 13: Glaucoma

Primary Open Angle GlaucomaPrimary Open Angle Glaucoma

Page 14: Glaucoma

Traumatic Hyphaema with Traumatic Hyphaema with secondary open angle glaucomasecondary open angle glaucoma

Page 15: Glaucoma

Pseudoexfoliative SyndromePseudoexfoliative Syndrome

Page 16: Glaucoma

Open Angle GlaucomaOpen Angle Glaucoma

Clinical features:Clinical features:

- ‘silent thief of sight’- ‘silent thief of sight’

- Painless gradual loss of vision; loss - Painless gradual loss of vision; loss of visual field follows by impairment of visual field follows by impairment of visual acuity.of visual acuity.

- Intraocular pressure (IOP) rise - Intraocular pressure (IOP) rise gradually, usually asymptomatic, till gradually, usually asymptomatic, till significant visual impairment occurs.significant visual impairment occurs.

Page 17: Glaucoma

This is what a glaucoma patient This is what a glaucoma patient sees….sees….

Page 18: Glaucoma

ExaminationExamination

1.1. Visual acuityVisual acuity

2.2. Pupil – afferent pupillary defectPupil – afferent pupillary defect

3.3. Intra-ocular Pressure (IOP)Intra-ocular Pressure (IOP)

- IOP > 21 mmHg- IOP > 21 mmHg

- IOP asymmetry > 3 mmHg- IOP asymmetry > 3 mmHg

Page 19: Glaucoma

4.4. Optic nerve head & retinal nerve fibre layer Optic nerve head & retinal nerve fibre layer assessmentassessment

- vertical cup-disc ratio (CDR) > 0.7- vertical cup-disc ratio (CDR) > 0.7

- Asymmetry of CDR > 0.2- Asymmetry of CDR > 0.2

- thinning & notching of neuroretinal rim, - thinning & notching of neuroretinal rim, nasalization & bayonetting of retinal vessels.. nasalization & bayonetting of retinal vessels..

(Normal NRR follow ‘ISNT rule’).(Normal NRR follow ‘ISNT rule’).

- Laminar dots sign- Laminar dots sign

- optic disc haemorrhage- optic disc haemorrhage

Page 20: Glaucoma

5. Evaluation of the angle5. Evaluation of the angle

GonioscopyGonioscopy

- open or close ?- open or close ?

- to exclude secondary cause of glaucoma- to exclude secondary cause of glaucoma

Page 21: Glaucoma

Angle StructureAngle Structure

Page 22: Glaucoma

Grading for Gonioscopy findingGrading for Gonioscopy finding

GradeGrade 00 II IIII IIIIII IVIV

ShafferShaffer closedclosed 1010°° 2020°° 3030°° 4040°°

ModifieModifie

ShafferShaffer

Schwalbe Schwalbe lineline

Not seenNot seen

SchwalbeSchwalbe

Line Line

visiblevisible

TrabTrab

MeshworkMeshwork

visiblevisible

Scleral Scleral spurspur

visiblevisible

Ciliary Ciliary

Body Body

visiblevisible

Page 23: Glaucoma

Shaffer Gonioscopic ClassificationShaffer Gonioscopic Classification

Page 24: Glaucoma

Eclipse SignEclipse Sign

Page 25: Glaucoma

6.6. Visual Field TestVisual Field Test

- Humphrey visual field is gold standard- Humphrey visual field is gold standard

- classical VF defects are - classical VF defects are

: : paracentral scotomaparacentral scotoma

nasal stepnasal step

Arcuate scotomaArcuate scotoma

Temporal wedgeTemporal wedge

Page 26: Glaucoma

Humprey Humprey Visual FieldVisual Field

Page 27: Glaucoma

Optic disc photographOptic disc photograph showing thinning of the inferior showing thinning of the inferior neuroretinal rim and increased cupping, consistent with neuroretinal rim and increased cupping, consistent with

glaucoma.glaucoma.Humphrey visual fieldHumphrey visual field showing showing superior arcuatesuperior arcuate defect defect and and nasal stepnasal step corresponding to the glaucomatous optic corresponding to the glaucomatous optic

nerve changes on the left.nerve changes on the left.

Page 28: Glaucoma

Management:Management:MedicalMedicaltopical anti-glaucoma topical anti-glaucoma - B-blocker eg Timolol, Betoptic- B-blocker eg Timolol, Betoptic- prostaglandin analog - prostaglandin analog - carbonic anhydrace inhibitor- carbonic anhydrace inhibitor- - αα agonist agonist Laser TreatmentLaser Treatment- Argon laser trabeculoplasty /Selective LT- Argon laser trabeculoplasty /Selective LTSurgicalSurgical- Trabeculectomy/augmented trabeculectomy- Trabeculectomy/augmented trabeculectomy- Shunt/valve surgery- Shunt/valve surgery

ConservativeConservative- asymptomatic poor visual prognosis- asymptomatic poor visual prognosis

Page 29: Glaucoma

Indications for surgery:Indications for surgery:

1.1. Failed medical therapyFailed medical therapy

2.2. Disease progression despite maximun Disease progression despite maximun medical therapymedical therapy

3.3. Anticipated fast progressionAnticipated fast progression

4.4. Combined cataract & trabeculectomy Combined cataract & trabeculectomy surgerysurgery

Page 30: Glaucoma

Primary Angle Closure Primary Angle Closure GlaucomaGlaucoma

Risk Factors:Risk Factors:

- - age, average 60 y-oldage, average 60 y-old

- female more common 4:1- female more common 4:1

- race: more common in SEA, Chinese, - race: more common in SEA, Chinese, Eskimos.Eskimos.

- Family: 1- Family: 1stst degree relatives increased risk . degree relatives increased risk .

Page 31: Glaucoma

Anatomical predisposing factorsAnatomical predisposing factors

1.1. Relatively anterior location of iris-lens Relatively anterior location of iris-lens diaphragm.diaphragm.

2.2. Shallow anterior chamberShallow anterior chamber3.3. Narrow entrance to the chamber angleNarrow entrance to the chamber angle

Eyes with PACGEyes with PACG have have-corneal diameter 0.25mm smaller than normal -corneal diameter 0.25mm smaller than normal eyeseyes- shallower anterior chamber (1.8mm)- shallower anterior chamber (1.8mm)- hypermetropic eyes- hypermetropic eyes

Page 32: Glaucoma

Secondary- Pupillary Block Secondary- Pupillary Block GlaucomaGlaucoma

Inflammatory with occlusio or seclusio Inflammatory with occlusio or seclusio pupillaepupillae

PhacomorphicPhacomorphic

Vitreous blocVitreous bloc

Silicone oilSilicone oil

Page 33: Glaucoma

Secondary-NonPupillary Block Secondary-NonPupillary Block GlaucomaGlaucoma

NeovascularNeovascular

Iridocorneal endothelial syndromIridocorneal endothelial syndrom

Ciliary tumour, iris cystCiliary tumour, iris cyst

Suprachoroidal haemorrhageSuprachoroidal haemorrhage

Iatrogenic- tight scleral buckling, post PRPIatrogenic- tight scleral buckling, post PRP

Page 34: Glaucoma

Clinical Features:Clinical Features:

Rapidly progressive blurring of visionRapidly progressive blurring of visionPeriocular pain and congestionPeriocular pain and congestionNausea and vomiting in severe cases.Nausea and vomiting in severe cases.

Slit-lamp exam:Slit-lamp exam:- ciliary flush/circumcornea injection- ciliary flush/circumcornea injection- high IOP (50 -100mmHg)- high IOP (50 -100mmHg)- cornea oedema w epithelial cysts- cornea oedema w epithelial cysts- shallow anterior chamber.- shallow anterior chamber.

Page 35: Glaucoma

Acute Management ofAcute Management of Angle Closure Angle Closure GlaucomaGlaucoma

To lower the IOP fastTo lower the IOP fast

- IV Diamox 500mg /IV Mannitol- IV Diamox 500mg /IV Mannitol

- Topical antiglaucoma- Topical antiglaucoma > pilocarpine 2%> pilocarpine 2%

> timolol 0.5%> timolol 0.5%

> prostaglandin > prostaglandin analog analog

Definitive treatmentDefinitive treatment

- laser peripheral iridectomy/ surgical - laser peripheral iridectomy/ surgical

Page 36: Glaucoma

Further managementFurther management

To To control IOPcontrol IOP to to stop disease stop disease progressionprogression

- IOP, optic nerve changes, visual field- IOP, optic nerve changes, visual field

MedicalMedical

- - ββ blocker, prostaglandin analog carbonic blocker, prostaglandin analog carbonic anhydrace inhibitor, anhydrace inhibitor, αα agonist agonist

SurgicalSurgical- Trabeculectomy- Trabeculectomy

- Shunt/valve surgery- Shunt/valve surgery

Page 37: Glaucoma

TrabeculotomyTrabeculotomy

Page 38: Glaucoma
Page 39: Glaucoma

Aquoues OutflowAquoues Outflow

Page 40: Glaucoma

Congenital GlaucomaCongenital Glaucoma

Page 41: Glaucoma

Congenital GlaucomaCongenital Glaucoma

Primary Primary SecondarySecondary - Anterior segment dysgenesis- Anterior segment dysgenesis- Ocular ds- Ocular ds- Phakomatoses eg. Neurofibromatosis- Phakomatoses eg. Neurofibromatosis- Metabolic ds eg. Lowe’s, Homocysteinuria- Metabolic ds eg. Lowe’s, Homocysteinuria- Congenital rubella- Congenital rubella- chromosomal abn eg. Down’s- chromosomal abn eg. Down’s- Ocular tumour- Ocular tumour- inflammatory eg. Seronegative arthritis- inflammatory eg. Seronegative arthritis

Page 42: Glaucoma

Clinical Features:Clinical Features:

May manifest at birth or develop laterMay manifest at birth or develop later

Signs & SymptomsSigns & Symptoms lacrimationlacrimation PhotophobiaPhotophobia Hazy corneaHazy cornea buphthalmosbuphthalmos rapidly progressive myopiarapidly progressive myopia

Page 43: Glaucoma

BuphthalmosBuphthalmos

Page 44: Glaucoma

Examination under anaesthesiaExamination under anaesthesia

Intraocular pressureIntraocular pressureAnterior segment examinationAnterior segment examination- cornea opacity, Haab’s striae- cornea opacity, Haab’s striae- anterior segment dysgenesis- anterior segment dysgenesisGonioscopyGonioscopy- Thicken trabecular meshwork, Barkhan’s - Thicken trabecular meshwork, Barkhan’s membranemembraneFundus examinationFundus examination- optic cup-disc ratio- optic cup-disc ratio

Page 45: Glaucoma

Management of Congenital GlaucomaManagement of Congenital Glaucoma

Congenital glaucoma is a surgical disease!Congenital glaucoma is a surgical disease!

SurgerySurgery goniotomy goniotomy trabeculotomytrabeculotomy trabeculectomytrabeculectomy

MedicalMedical topical eye drops ie. topical eye drops ie. ΒΒ-blocker, carbonic anhydrace -blocker, carbonic anhydrace

inhibitor, prostaglandin analoginhibitor, prostaglandin analog Alfa-2 agonist contraindicated due to sedative effectAlfa-2 agonist contraindicated due to sedative effect

Page 46: Glaucoma

GoniotomyGoniotomy

Barkhan Goniotomy lens & Swan goniotomy knife

Page 47: Glaucoma

Thank YouThank You